Department of Urology, University of Rochester Medical Center, 601 Elmwood Ave, Box 656, Rochester, NY, 14642, USA.
Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Stem Cell Res Ther. 2021 Oct 9;12(1):533. doi: 10.1186/s13287-021-02600-6.
Chemosenstive non-stem cancer cells (NSCCs) constitute the bulk of tumors and are considered as part of the cancer stem cell (CSC) niche in the tumor microenvironment (TME). Tumor-derived extracellular vesicles (EVs) mediate the communication between tumors and the TME. In this study, we sought to investigate the impacts of EVs released by NSCCs on the maintenance of CSC properties and chemoresistance.
We employed murine MB49 bladder cancer (BC) sub-lines representing CSCs and NSCCs as a model system. Chemotherapy drugs were used to treat NSCCs in order to collect conditioned EVs. The impacts of NSCC-derived EVs on CSC progression were evaluated through sphere formation, cytotoxicity, migration, and invasion assays, and by analyzing surface marker expression on these BC cells. Differential proteomic analyses were conducted to identify cargo protein candidates involved in the EV-mediated communication between NSCCs and CSCs.
NSCC-derived EVs contained cargo proteins enriched in proteostasis-related functions, and significantly altered the development of CSCs such that they were more intrinsically chemoresistant, aggressive, and better able to undergo self-renewal.
We thus identified a novel communication mechanism whereby NSCC-EVs can alter the relative fitness of CSCs to promote disease progression and the acquisition of chemoresistance.
化学敏感性非干细胞癌细胞 (NSCCs) 构成了肿瘤的大部分,被认为是肿瘤微环境 (TME) 中癌症干细胞 (CSC) 生态位的一部分。肿瘤来源的细胞外囊泡 (EVs) 介导了肿瘤与 TME 之间的通讯。在这项研究中,我们试图研究 NSCC 释放的 EVs 对 CSC 特性和化疗耐药性维持的影响。
我们使用代表 CSCs 和 NSCCs 的小鼠 MB49 膀胱癌 (BC) 亚系作为模型系统。用化疗药物处理 NSCCs 以收集条件性 EVs。通过球体形成、细胞毒性、迁移和侵袭测定,以及分析这些 BC 细胞表面标志物的表达,评估 NSCC 衍生的 EVs 对 CSC 进展的影响。进行差异蛋白质组学分析以鉴定参与 NSCC 和 CSC 之间 EV 介导通讯的货物蛋白候选物。
NSCC 衍生的 EVs 包含富含蛋白质稳态相关功能的货物蛋白,并显著改变了 CSCs 的发育,使它们对化疗更具内在耐药性、侵袭性和自我更新能力更强。
因此,我们确定了一种新的通讯机制,即 NSCC-EVs 可以改变 CSCs 的相对适应性,从而促进疾病进展和获得化疗耐药性。